KDR and kidney cancer: The following immune cells can be removed from a patient, can be genetically modified and re-introduced into the patient and used in kidney cancer in clinical studies: CD8+ cells anti-VEGFR2 gene engineered; natural killer (NK) cells, important innate immune cells, in patients with kidney cancer.